Effect of Chinese Herbal Medicine on Kidney Function in Non-Diabetic CKD

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This study is a prospective, single‐blind (data analyst‐blinded), randomized controlledpilot trial evaluating a traditional Chinese medicine formula (CKD‐1) as adjunctivetherapy in patients with stage 3‐4 non‐diabetic chronic kidney disease. Chronic kidneydisease is a progressive condition with limited treatment options to slow renaldeterioration. Traditional Chinese medicine is widely used as a complementary approach,but clinical evidence remains limited. This trial is designed to provide preliminaryclinical evidence on the potential role of CKD‐1 in improving renal outcomes andsupporting future large‐scale randomized controlled trials.
Epistemonikos ID: e72ff3c92d5ce8ad2d361d3f64c6d7c92858f17a
First added on: Jun 18, 2026